Decision of the EEA Joint Committee No 171/2026 of 5 June 2026 amending Annex II ... (22026D2006)
Decision of the EEA Joint Committee No 171/2026 of 5 June 2026 amending Annex II ... (22026D2006)
2026/2006
24.9.2026
DECISION OF THE EEA JOINT COMMITTEE No 171/2026
of 5 June 2026
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/2006]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2026/351 of 18 February 2026 renewing the approval of the active substance spinosad in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 ( 1 ) , as corrected by OJ L, 2026/90291, 17.4.2026 , is to be incorporated into the EEA Agreement.
(2) Commission Implementing Regulation (EU) 2026/355 of 18 February 2026 renewing the approval of the active substance pyrimethanil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 ( 2 ) is to be incorporated into the EEA Agreement.
(3) Commission Implementing Regulation (EU) 2026/398 of 18 February 2026 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-ol ( 3 ) is to be incorporated into the EEA Agreement.
(4) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II to the EEA Agreement is amended as follows:
1.
The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):
‘—
32026 R 0351 : Commission Implementing Regulation (EU) 2026/351 of 18 February 2026 ( OJ L, 2026/351, 19.2.2026 ), as corrected by OJ L, 2026/90291, 17.4.2026 ,
— 32026 R 0355 : Commission Implementing Regulation (EU) 2026/355 of 18 February 2026 ( OJ L, 2026/355, 19.2.2026 ).’
2.
The following points are inserted after point 13zzzzzzzzzzzzzzzr (Commission Implementing Regulation (EU) 2026/312):
‘13zzzzzzzzzzzzzzzs.
32026 R 0351 : Commission Implementing Regulation (EU) 2026/351 of 18 February 2026 renewing the approval of the active substance spinosad in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L, 2026/351, 19.2.2026 ), as corrected by OJ L, 2026/90291, 17.4.2026 .
13zzzzzzzzzzzzzzzt.
32026 R 0355 : Commission Implementing Regulation (EU) 2026/355 of 18 February 2026 renewing the approval of the active substance pyrimethanil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L, 2026/355, 19.2.2026 ).’
3.
The following indent is added in point 13zzze (Commission Implementing Regulation (EU) No 686/2012):
‘—
32026 R 0398 : Commission Implementing Regulation (EU) 2026/398 of 18 February 2026 ( OJ L, 2026/398, 19.2.2026 ).’
Article 2
The texts of Implementing Regulations (EU) 2026/351, as corrected by OJ L, 2026/90291, 17.4.2026 , (EU) 2026/355 and (EU) 2026/398 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.
Article 3
This Decision shall enter into force on 6 June 2026, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .
Done at Brussels, 5 June 2026.
For the EEA Joint Committee
The President
Nicolas VON LINGEN
( 1 ) OJ L, 2026/351, 19.2.2026, ELI: http://data.europa.eu/eli/reg_impl/2026/351/oj .
( 2 ) OJ L, 2026/355, 19.2.2026, ELI: http://data.europa.eu/eli/reg_impl/2026/355/oj .
( 3 ) OJ L, 2026/398, 19.2.2026, ELI: http://data.europa.eu/eli/reg_impl/2026/398/oj .
( *1 ) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2026/2006/oj
ISSN 1977-0677 (electronic edition)